Avandia to Remain on the Market

According to a news report on CNN.com, July 30th, 2007 marked the day that the FDA joint advisory committee recommended that rosiglitazone (Avandia) remain on the market for now, by a vote of 22 to 1. Read the whole story on CNN.com/health

• FDA panel: Keep Avandia on the market

GlaxoSmithKline also issued a press release, announcing the FDA's joint advisory committee's decision, stating it will "continue to provide information to the FDA to assist in the Agency's final decision-making."

The FDA frequently abides by it's advisory committee's decisions, according to CNN.com.